FDA oks Lymphoseek for more multiple cancer diagnosis The FDA has approved the injectable lymphatic mapping agent Lymphoseek for a second time. Originally used as a diagnostic tool in breast cancer and melanoma, it will now help doctors treat head and neck cancers. by Mark Hawver